Modi govt increased 12,000 medical seats: Nadda

New Delhi ,ANI): Union Health Minister J P Nadda on Friday said that the Narendra Modi led National Democratic Alliance (NDA) government has increased 12,000 medical seats.

Talking to reporters here, Nadda said not only the medical seats but also undergraduate and postgraduate seats have been increased in the last four years.

“When this government came to power in 2014, there was 52,000 undergraduate (UG) and 30,000 postgraduate (PG) medical seats. Today, we have not only increased 12,000 medical seats but also the total number of UG seats have risen to 85,525 and PG seats to 46,000,” Nadda said.

It is to be noted that the Cabinet Committee on Economic Affairs (CCEA) chaired by Prime Minister Modi, on Wednesday, gave its approval for setting up 24 new medical colleges in underserved areas.

The Cabinet has also given approval for setting up 112 Auxiliary Nursing and Midwifery (ANM) Schools and 136 General Nursing Midwifery (GNM) Schools by 2019-20 in underserved districts. (ANI)

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

    Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

    250% rally in one year! Multibagger pharma stock jumps despite stock market crash

    250% rally in one year! Multibagger pharma stock jumps despite stock market crash